News from Veriton Pharma on Epistatus
Acquired Brain Injury Alliance Launches Rehabilitation Prescription Campaign
New of the Rehabilitation Prescription campaign
Renishaw neuromate® stereotactic robot assists SEEG procedures at The Walton Centre, Liverpool
News from Renishaw and The Walton Centre
Merck at The AAN
News of Mavenclad and Rebif from Merck at The AAN
Genentech at The AAN
News of forthcoming presentations from Genentech, a member of the Roche Group, during the 70th American Academy of Neurology (AAN) Annual Meeting
UKABIF Film Awards 2018 now open for entries
News from The United Kingdom Acquired Brain Injury Forum
Healthcare professionals and patients publish recommendations to tackle multiple sclerosis in a joint publication
News from Merck about “MS in the 21st Century”
Canon Medical Systems UK recognised as carbon zero hero
News from Canon Medical Systems
Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA® (daclizumab) for Relapsing Multiple Sclerosis
ZINBRYTA withdrawn by Biogen and AbbVie
